Sort
21,453 grants matching “tuberculosis”
CRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary disease
$866,858Kevin Loring Winthrop · Oregon Health & Science University · R01 · FY2024 · AI
Core E Animal Infection Models
$866,758David S Perlin · Hackensack University Medical Center · U19 · FY2020 · AI
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$866,688Smriti Mehra · Tulane University Of Louisiana · R01 · FY2018 · AI
Diversity Center for Genome Research at Meharry
$866,227Anil Shanker · Meharry Medical College · UG3 · FY2023 · HG
Innate, Transcriptomic, and Microbiomic correlates of TB infection
$866,176Michael Haggai Glickman · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention
$866,149Eric L Nuermberger · Johns Hopkins University · R01 · FY2019 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$865,920Ann R Falsey · University Of Rochester · UM1 · FY2025 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM FUNDING
$865,692Barry Dickman · Philadelphia Departmentof Public Health · U52 · FY2011 · PS
India International Center for Excellence in Research
$865,570Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Multivalent DNA vaccine-mediated protection against Tuberculosis
$865,253David B. Weiner · Wistar Institute · R01 · FY2022 · AI
Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications
$865,106Glenn Martin · Nota Laboratories, Llc · R42 · FY2022 · HL
Host Determinants of TB Disease Progression
$864,766Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2016 · AI
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$864,661Shabaana A. Khader · Washington University · R01 · FY2022 · AI
Clinical Core
$864,157Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$863,755Jyothi Rengarajan · Emory University · R01 · FY2024 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$861,780Beth Israel Medical Ctr (New York) · U01 · FY2000 · AI
Targets in Mycobacterium Tuberculosis: Stress Resistance & Repair
$861,514Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2008 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$861,286Chiyome L Fukino · Hawaii State Department Of Health · U52 · FY2007 · PS
DOT Diary (D2): Developing a mobile app with combined automated DOT and daily sexual diary for monitoring and improving PrEP adherence
$861,189Susan Buchbinder · Public Health Foundation Enterprises · R01 · FY2016 · MH
Minimizing in vivo Drug Tolerance induction in tuberculosis.
$861,173David G Russell · Rutgers Biomedical And Health Sciences · U19 · FY2025 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$861,166Jyothi Rengarajan · Emory University · R01 · FY2022 · AI
Targeting protein secretion in Mycobacterium tuberculosis
$861,105Tanya Parish · Seattle Children'S Hospital · R01 · FY2025 · AI
Hybrid Antibiotics for Persistent Infections
$860,889Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Conservation and Sustainable Use of Biodiversity in PNG
$860,825Louis R Barrows · University Of Utah · U01 · FY2010 · TW
CD4-Independent Vaccinations for Pulmonary Infections
$860,610Jay K Kolls · Lsu Health Sciences Center · P01 · FY2007 · HL